Chest Pain
Welcome,         Profile    Billing    Logout  
 30 Companies   45 Products   45 Products   68 Mechanisms of Action   2 Trials   656 News 


«12345678910111213»
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Correlation of High Resolution Esophageal Manometry With Symptoms (clinicaltrials.gov) -  Apr 10, 2017   
    P=N/A,  N=0, Withdrawn, 
    N=300 --> 0 | Terminated --> Withdrawn | Trial primary completion date: Feb 2013 --> Aug 2011
  • ||||||||||  Trial completion, Trial primary completion date:  SCOT-HEART: Scottish COmputed Tomography of the HEART Trial (clinicaltrials.gov) -  Apr 10, 2017   
    P=N/A,  N=4138, Completed, 
    N=300 --> 0 | Terminated --> Withdrawn | Trial primary completion date: Feb 2013 --> Aug 2011 Recruiting --> Completed | Trial primary completion date: Apr 2014 --> May 2015
  • ||||||||||  Trial completion, Trial primary completion date:  CAESA: Phase III Trial of Dantonic (clinicaltrials.gov) -  Mar 9, 2017   
    P3,  N=1004, Completed, 
    Not yet recruiting --> Completed | N=460 --> 43 Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Dec 2016
  • ||||||||||  Trial completion, Phase classification, Enrollment change:  Chest Pain Observation Unit Risk Reduction Trial (clinicaltrials.gov) -  Mar 7, 2017   
    P=N/A,  N=140, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Dec 2016 Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | N=240 --> 140
  • ||||||||||  nicorandil / Generic mfg.
    Trial completion, Trial primary completion date:  GzFFR: A Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=108, Completed, 
    Trial primary completion date: Mar 2016 --> Mar 2019 Recruiting --> Completed | Trial primary completion date: Jul 2016 --> Oct 2016
  • ||||||||||  Aimovig (erenumab-aooe) / Amgen, Novartis
    Enrollment closed, Enrollment change:  Treadmill Cardiovascular Safety Study of Erenumab (AMG 334) (clinicaltrials.gov) -  Feb 9, 2017   
    P2,  N=89, Active, not recruiting, 
    Phase classification: P4 --> P=N/A Recruiting --> Active, not recruiting | N=120 --> 89
  • ||||||||||  Biomarker, Trial primary completion date:  Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19 (clinicaltrials.gov) -  Jan 26, 2017   
    P=N/A,  N=1000, Recruiting, 
    Recruiting --> Active, not recruiting | N=120 --> 89 Trial primary completion date: Nov 2016 --> Mar 2017
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  High-intensity Exercise After Acute Cardiac Event (HITCARE) (clinicaltrials.gov) -  Jan 24, 2017   
    P=N/A,  N=27, Terminated, 
    Trial primary completion date: Nov 2016 --> Mar 2017 N=750 --> 27 | Not yet recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Nov 2016; Recruitment was stopped due to lack of funding.
  • ||||||||||  Enrollment open:  EMPACT: The Evaluation and Management of Patients With Acute ChesT Pain in China (clinicaltrials.gov) -  Jan 18, 2017   
    P=N/A,  N=10000, Recruiting, 
    N=750 --> 27 | Not yet recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Nov 2016; Recruitment was stopped due to lack of funding. Not yet recruiting --> Recruiting
  • ||||||||||  atorvastatin / Generic mfg.
    Trial initiation date, Trial primary completion date:  STAVA: Statin Therapy In Patients With Vasospastic Angina (clinicaltrials.gov) -  Dec 8, 2016   
    P4,  N=1000, Not yet recruiting, 
    Trial primary completion date: Jan 2016 --> Jan 2017 Initiation date: Jul 2016 --> Jul 2017 | Trial primary completion date: Jun 2022 --> Jun 2023
  • ||||||||||  Kengreal (cangrelor) / Chiesi
    Enrollment open:  The Effect of IV Cangrelor and Oral Ticagrelor Study (clinicaltrials.gov) -  Oct 26, 2016   
    P4,  N=100, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Apr 2016 Not yet recruiting --> Recruiting
  • ||||||||||  Trial primary completion date:  Danhong Injection in the Treatment of Unstable Angina Pectoris (clinicaltrials.gov) -  Oct 11, 2016   
    P4,  N=160, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Dec 2016 --> Jun 2017
  • ||||||||||  Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
    Enrollment change, Trial withdrawal:  ACSSLAP: Acute Coronary Syndrome Sri Lanka Audit Project (clinicaltrials.gov) -  Oct 11, 2016   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: Dec 2016 --> Jun 2017 N=2380 --> 0 | Completed --> Withdrawn
  • ||||||||||  Enrollment closed, Enrollment change:  FUTURE: Functional Testing Underlying Coronary Revascularisation (clinicaltrials.gov) -  Oct 5, 2016   
    P=N/A,  N=941, Active, not recruiting, 
    N=2380 --> 0 | Completed --> Withdrawn Recruiting --> Active, not recruiting | N=1728 --> 941
  • ||||||||||  Trial completion, Enrollment change:  PERCEPIC: PERC Rule Combined With Implicit Low Clinical Probability (clinicaltrials.gov) -  Sep 22, 2016   
    P=N/A,  N=1773, Completed, 
    Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jun 2016 Recruiting --> Completed | N=3000 --> 1773